Side-Effects of Anti-Inflammatory Drugs 3

Table of Contents

1. Altmetric Badge
   Book Overview
2. Altmetric Badge
   Chapter 1 The gastrointestinal toxicity of the non-steroidal anti-inflammatory drugs
3. Altmetric Badge
   Chapter 2 The value of the case—control approach for the evaluation of the risk of upper gastrointestinal bleeding associated with the previous use of non-steroidal anti-inflammatory drugs
4. Altmetric Badge
   Chapter 3 Liver toxicity of antipyretic drugs in conjunction with measles infections
5. Altmetric Badge
   Chapter 4 Non-steroidal anti-inflammatory drugs and hypersensitivity reactions
6. Altmetric Badge
   Chapter 5 What can a spontaneous reporting system teach about side-effects of anti-inflammatory drugs?
7. Altmetric Badge
   Chapter 6 Adverse reactions to NSAIDs: Consecutive evaluation of 30,000 patients in rheumatology
8. Altmetric Badge
   Chapter 7 The evaluation of acute gastrointestinal toxicity of NSAIDs in phase I clinical trials: a critical appraisal
9. Altmetric Badge
   Chapter 8 The ulcerogenic and anti-haemostatic effects of NSAIDs in the gut
10. Altmetric Badge
    Chapter 9 What role does Helicobacter pylori infection play in NSAID-associated gastric inflammation?
11. Altmetric Badge
    Chapter 10 Endoscopic evaluation of NSAID ulceration
12. Altmetric Badge
    Chapter 11 Food antigen absorption in rheumatoid arthritis: effect of acetylsalicylic acid
13. Altmetric Badge
    Chapter 12 Intestinal mucosal permeability in inflammatory rheumatic diseases
14. Altmetric Badge
    Chapter 13 Comparison of effects on gastrointestinal blood loss and gastric mucosal appearance of piroxicam-β-cyclodextrin, piroxicam and placebo
15. Altmetric Badge
    Chapter 14 Mechanisms of gastrointestinal ulceration from non-steroidal anti-inflammatory drugs: a basis for use and development of protective agents
16. Altmetric Badge
    Chapter 15 Novel strategies of gastric and duodenal mucosal protection against NSAID injury: role of protease inhibitors, muscle relaxants and growth factors
17. Altmetric Badge
    Chapter 16 The role of misoprostol in preventing NSAID-induced damage to the gastrointestinal tract
18. Altmetric Badge
    Chapter 17 Possible factors involved in the protective effects of interleukin-1 in aspirin- and indomethacin-induced gastric damage
19. Altmetric Badge
    Chapter 18 Prevention and treatment of NSAID-gastroduodenal damage: the role of H 2 -receptor antagonists
20. Altmetric Badge
    Chapter 19 Omeprazole in the prevention and therapy of gastroduodenal lesions on NSAID therapy
21. Altmetric Badge
    Chapter 20 Sucralfate in the prevention of NSAID-induced gastric ulceration
22. Altmetric Badge
    Chapter 21 Ketotifen — a novel approach to the prevention of damage in the gastrointestinal tract
23. Altmetric Badge
    Chapter 22 The hepatotoxicity of non-steroidal anti-inflammatory drugs
24. Altmetric Badge
    Chapter 23 Paracetamol (acetaminophen) bioactivation by liver microsomes — its role in hepatotoxicity
25. Altmetric Badge
    Chapter 24 Increased liver toxicity of diclofenac by paracetamol: results and possible mechanisms
26. Altmetric Badge
    Chapter 25 Effects of NSAIDs on liver microsomal mono-oxygenase system and products of oxidative metabolism of arachidonic acid
27. Altmetric Badge
    Chapter 26 Hepatitis due to non-steroidal anti-inflammatory drugs (NSAIDs)
28. Altmetric Badge
    Chapter 27 Current status of nephrotoxicity caused by non-steroidal anti-inflammatory drugs
29. Altmetric Badge
    Chapter 28 Are oral prostaglandins effective in preventing nephrotoxicity from NSAIDs and cyclosporin?
30. Altmetric Badge
    Chapter 29 Aspirin and Reye’s syndrome
31. Altmetric Badge
    Chapter 30 Antirheumatic drug therapy in the elderly
32. Altmetric Badge
    Chapter 31 NSAIDs and human cartilage metabolism
33. Altmetric Badge
    Chapter 32 Non-steroidal anti-inflammatory drugs and the augmented lipoxygenase pathway: conceivable impact on joint conditions
34. Altmetric Badge
    Chapter 33 Therapeutic potential of 5-lipoxygenase inhibitors: the discovery and development of MK-886, a novel-mechanism leukotriene inhibitor
35. Altmetric Badge
    Chapter 34 Mechanisms of rash formation and related skin conditions induced by non-steroidal anti-inflammatory drugs
36. Altmetric Badge
    Chapter 35 Cyclosporin: clinical efficacy and toxicity in patients with rheumatoid arthritis
37. Altmetric Badge
    Chapter 36 Risk factors and risk—benefit problems in the use of DMARDs
38. Altmetric Badge
    Chapter 37 Gold toxicity: chemical, structural, biological and clinical experimental issues
39. Altmetric Badge
    Chapter 38 A review of interaction studies between non-steroidal anti-inflammatory drugs and H 2 -receptor antagonists or prostaglandin analogues
40. Altmetric Badge
    Chapter 39 Influence of different anti-inflammatory substances on ethanol- and indomethacin induced gastrointestinal mucosal damage
41. Altmetric Badge
    Chapter 40 The role of copper in preventing gastric damage by acetylsalicylic acid
42. Altmetric Badge
    Chapter 41 Effect of NSAID therapy on plasma, whole blood cell (BC), and 24h urine zinc in patients with rheumatoid arthritis (RA)